drugset / Trial / NCT02725242

Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma

NCT02725242 ↗

Phase 3 Completed 77 enrolled Hat Yai Medical Education Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the efficacy of Once-daily Budesonide/formoterol Turbuhaler 160/4.5 µg/d in the period of step down in well controlled asthmatic patient.

Timeline

Start
2016-03
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 160 ug —
Subject Budesonide Small molecule 200 ug —
Subject Formoterol Other / unclassified 4.5 ug —

Indications